https://scholars.lib.ntu.edu.tw/handle/123456789/570928
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | HSIANG-FONG KAO | en_US |
dc.contributor.author | PEI-JEN LOU | en_US |
dc.date.accessioned | 2021-07-12T08:46:24Z | - |
dc.date.available | 2021-07-12T08:46:24Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1043-3074 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072762765&doi=10.1002%2fhed.25930&partnerID=40&md5=e426a378aef6531d25a937cc57fb5f11 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/570928 | - |
dc.publisher | John Wiley and Sons Inc. | en_US |
dc.relation.ispartof | Head and Neck | en_US |
dc.title | Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions | en_US |
dc.type | conference paper | en_US |
dc.identifier.doi | 10.1002/hed.25930 | - |
dc.identifier.pmid | 31573752 | - |
dc.identifier.scopus | 2-s2.0-85072762765 | - |
dc.relation.pages | 4-18 | en_US |
dc.relation.journalvolume | 41 | en_US |
dc.relation.journalissue | S1 | en_US |
item.openairetype | conference paper | - |
item.openairecristype | http://purl.org/coar/resource_type/c_5794 | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.dept | Otolaryngology | - |
crisitem.author.dept | Otolaryngology-NTUH | - |
crisitem.author.orcid | 0000-0001-9186-0134 | - |
crisitem.author.orcid | 0000-0002-3383-8593 | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。